TELA Bio
TELA
47 hedge funds and large institutions have $146M invested in TELA Bio in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
20% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 15
7% more funds holding
Funds holding: 44 → 47 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.52% less ownership
Funds ownership: 67.68% → 67.16% (-0.52%)
10% less capital invested
Capital invested by funds: $161M → $146M (-$15.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.56M |
| 2 |
State Street
Boston,
Massachusetts
|
+$481K |
| 3 |
RPC
Rossmore Private Capital
Glastonbury,
Connecticut
|
+$397K |
| 4 |
PVI
Pura Vida Investments
New York
|
+$336K |
| 5 |
WP
WMS Partners
Towson,
Maryland
|
+$257K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.85M |
| 2 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$880K |
| 3 |
SMH
Sanders Morris Harris
Houston,
Texas
|
-$807K |
| 4 |
SAM
Silvercrest Asset Management
New York
|
-$755K |
| 5 |
CCM
CAAS Capital Management
New York
|
-$251K |
TELA Hedge Fund Activity: Q4 2020 in Review
47 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q4 2020, worth a combined $146M — down 9.7% from $161M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TELA positions and 1 closed out — a net gain of 3 holders — while 18 added to existing stakes and 15 trimmed.
The largest buyer was Armistice Capital, adding an estimated $1.56M. The largest seller was Alyeska Investment Group, cutting an estimated $1.85M.
- 47 institutional investors held TELA Bio (TELA) as of Q4 2020, up from 44 in Q3 2020.
- Funds reported $146M of TELA Bio stock for Q4 2020, down 9.7% quarter-over-quarter.
- 4 funds opened new TELA Bio positions in Q4 2020 and 1 closed out, a net change of +3 holders.
- The largest TELA Bio buyer in Q4 2020 was Armistice Capital, an estimated $1.56M added.
- The largest TELA Bio seller in Q4 2020 was Alyeska Investment Group, an estimated $1.85M sold.
Based on aggregated 13F filings for Q4 2020.